Analysts’ Recent Ratings Updates for Quantinuum (QNT)

A number of firms have modified their ratings and price targets on shares of Quantinuum (NASDAQ: QNT) recently:

• 8/19/2026 – Quantinuum had its “buy” rating reaffirmed by Rosenblatt Securities. They now have a $155.00 price target on the stock.
• 8/12/2026 – Quantinuum had its “hold” rating reaffirmed by Sanford C. Bernstein.
• 8/12/2026 – Quantinuum had its price target raised by Sanford C. Bernstein from $94.00 to $95.00. They now have an “outperform” rating on the stock.
• 8/12/2026 – Quantinuum was given a new $85.00 price target by Jefferies Financial Group Inc..
• 8/12/2026 – Quantinuum had its “buy” rating reaffirmed by Rosenblatt Securities. They now have a $155.00 price target on the stock.
• 8/12/2026 – Quantinuum had its “overweight” rating reaffirmed by Cantor Fitzgerald. They now have a $90.00 price target on the stock.
• 8/12/2026 – Quantinuum had its “buy” rating reaffirmed by Needham & Company LLC. They now have a $100.00 price target on the stock.
• 7/4/2026 – Quantinuum was downgraded by Wall Street Zen from “hold” to “sell”.
• 6/30/2026 – Quantinuum was upgraded by Zacks Research to “hold”.
• 6/29/2026 – Quantinuum is now covered by Cantor Fitzgerald. They set an “overweight” rating and a $90.00 price target on the stock.
• 6/29/2026 – Quantinuum is now covered by TD Cowen. They set a “buy” rating on the stock.
• 6/29/2026 – Quantinuum is now covered by Evercore Inc. They set an “outperform” rating and a $98.00 price target on the stock.
• 6/29/2026 – Quantinuum is now covered by UBS Group AG. They set a “buy” rating and a $93.00 price target on the stock.
• 6/29/2026 – Quantinuum was given a new $78.00 price target by UBS Group AG.
• 6/29/2026 – Quantinuum is now covered by Jefferies Financial Group Inc.. They set a “buy” rating and a $90.00 price target on the stock.
• 6/29/2026 – Quantinuum is now covered by UBS Group AG. They set a “buy” rating and a $93.00 price target on the stock.
• 6/29/2026 – Quantinuum is now covered by Jefferies Financial Group Inc.. They set a “buy” rating and a $90.00 price target on the stock.
• 6/29/2026 – Quantinuum is now covered by Evercore Inc. They set an “outperform” rating on the stock.
• 6/29/2026 – Quantinuum is now covered by Cantor Fitzgerald. They set an “overweight” rating and a $90.00 price target on the stock.
• 6/29/2026 – Quantinuum is now covered by Morgan Stanley. They set an “equal weight” rating and a $78.00 price target on the stock.
• 6/29/2026 – Quantinuum is now covered by JPMorgan Chase & Co.. They set an “overweight” rating and a $97.00 price target on the stock.
• 6/29/2026 – Quantinuum is now covered by Sanford C. Bernstein. They set an “outperform” rating and a $94.00 price target on the stock.
• 6/29/2026 – Quantinuum is now covered by Craig Hallum. They set a “buy” rating and a $100.00 price target on the stock.
• 6/29/2026 – Quantinuum is now covered by Mizuho. They set an “outperform” rating and a $90.00 price target on the stock.
• 6/29/2026 – Quantinuum is now covered by Rosenblatt Securities. They set a “buy” rating and a $155.00 price target on the stock.
• 6/29/2026 – Quantinuum is now covered by Bank of America Corporation. They set a “buy” rating and a $100.00 price target on the stock.
• 6/29/2026 – Quantinuum is now covered by Needham & Company LLC. They set a “buy” rating and a $100.00 price target on the stock.

Insiders Place Their Bets

In related news, insider Kevin Scott Dehoff purchased 15,000 shares of Quantinuum stock in a transaction dated Friday, June 5th. The stock was purchased at an average cost of $60.00 per share, for a total transaction of $900,000.00. Following the completion of the purchase, the insider directly owned 126,460 shares of the company’s stock, valued at $7,587,600. The trade was a 13.46% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Kenneth D. Denman acquired 14,000 shares of the firm’s stock in a transaction dated Friday, June 5th. The shares were bought at an average cost of $60.00 per share, with a total value of $840,000.00. Following the completion of the acquisition, the director directly owned 19,833 shares of the company’s stock, valued at $1,189,980. The trade was a 240.01% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have bought 411,032 shares of company stock worth $24,661,920 in the last quarter.

Quantinuum is a quantum computing company focused on developing hardware and software for commercial and scientific applications. The company provides access to its quantum systems, along with software tools and services designed to help customers explore use cases in areas such as optimization, materials science, chemistry, cybersecurity, and machine learning.

The company was formed through the combination of Honeywell Quantum Solutions and Cambridge Quantum in 2021. Quantinuum operates internationally and serves a range of customers across enterprise, government, and research markets.